FDA Deputy Commissioner for Policy, Planning, Legislation, and Analysis Anna Abram, remarks prepared for testimony before a subcommittee of the U.S. House Committee on Energy and Commerce on the Pandemic and All-Hazards Preparedness Act

FDA ’ s Anna Abram ’ s testimony for U.S. House Committee on Energy and Commerce Subcommittee on Health on the Pandemic and All-Hazards Preparedness Act

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610081.htm

Source: Food and Drug Administration - June 6, 2018 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA) | Pandemics